Polen: BD Aiming For Higher Growth Spaces And More Tuck-Ins
Executive Summary
BD stressed the continued pursuit of an innovation-driven growth strategy as it announced fiscal 2021 sales of $20bn spurred by its pandemic response effort.
You may also be interested in...
BD Plans To Spin Off Diabetes Care Business
BD believes the independent new company will create shareholder value and is part of the BD 2025 growth strategy.
Olympus Medical Follows The Patient Pathway In New Strategic Plan
Having divested non-medical imaging a year ago, Olympus Corp is putting its foot to the floor in refocusing on its medical portfolio. It has set global ambitions of strengthening its coverage of unmet needs and of playing a major role in reshaping health care delivery.
Olympus Medical Follows The Patient Pathway In New Strategic Plan
Having divested non-medical imaging a year ago, Olympus Corp is putting its foot to the floor in refocusing on its medical portfolio. It has set global ambitions of strengthening its coverage of unmet needs and of playing a major role in reshaping health care delivery.